Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

NCT03470103 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03470103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03470103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
March 28, 2018
Completion date
January 15, 2021
Enrollment
643 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration